618 related articles for article (PubMed ID: 33509301)
21. Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation.
Aragão Gomes L; Uytterhoeven V; Lopez-Sanmartin D; Tomé SO; Tousseyn T; Vandenberghe R; Vandenbulcke M; von Arnim CAF; Verstreken P; Thal DR
Acta Neuropathol; 2021 Feb; 141(2):173-192. PubMed ID: 33427938
[TBL] [Abstract][Full Text] [Related]
22. Early but not late conformational changes of tau in association with ubiquitination of neurofibrillary pathology in Alzheimer's disease brains.
Ibarra-Bracamontes VJ; Escobar-Herrera J; Kristofikova Z; Rípova D; Florán-Garduño B; Garcia-Sierra F
Brain Res; 2020 Oct; 1744():146953. PubMed ID: 32526294
[TBL] [Abstract][Full Text] [Related]
23. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
[TBL] [Abstract][Full Text] [Related]
24. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
25. Involvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease.
Takata K; Kitamura Y; Nakata Y; Matsuoka Y; Tomimoto H; Taniguchi T; Shimohama S
Am J Pathol; 2009 Jul; 175(1):17-24. PubMed ID: 19497998
[TBL] [Abstract][Full Text] [Related]
26. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
[TBL] [Abstract][Full Text] [Related]
27. Minimalistic in vitro systems for investigating tau pathology.
Hallinan GI; Pitera AP; Patel P; West J; Deinhardt K
J Neurosci Methods; 2019 May; 319():69-76. PubMed ID: 30278185
[TBL] [Abstract][Full Text] [Related]
28. The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice.
Di J; Siddique I; Li Z; Malki G; Hornung S; Dutta S; Hurst I; Ishaaya E; Wang A; Tu S; Boghos A; Ericsson I; Klärner FG; Schrader T; Bitan G
Alzheimers Res Ther; 2021 Jan; 13(1):6. PubMed ID: 33397489
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles.
Spillantini MG; Crowther RA; Goedert M
Acta Neuropathol; 1996 Jul; 92(1):42-8. PubMed ID: 8811124
[TBL] [Abstract][Full Text] [Related]
30. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
31. Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease.
Pooler AM; Polydoro M; Maury EA; Nicholls SB; Reddy SM; Wegmann S; William C; Saqran L; Cagsal-Getkin O; Pitstick R; Beier DR; Carlson GA; Spires-Jones TL; Hyman BT
Acta Neuropathol Commun; 2015 Mar; 3():14. PubMed ID: 25853174
[TBL] [Abstract][Full Text] [Related]
32. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity.
Ahmed Z; Cooper J; Murray TK; Garn K; McNaughton E; Clarke H; Parhizkar S; Ward MA; Cavallini A; Jackson S; Bose S; Clavaguera F; Tolnay M; Lavenir I; Goedert M; Hutton ML; O'Neill MJ
Acta Neuropathol; 2014 May; 127(5):667-83. PubMed ID: 24531916
[TBL] [Abstract][Full Text] [Related]
33. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy.
Iba M; Guo JL; McBride JD; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2013 Jan; 33(3):1024-37. PubMed ID: 23325240
[TBL] [Abstract][Full Text] [Related]
34. Hyperphosphorylation determines both the spread and the morphology of tau pathology.
Hu W; Zhang X; Tung YC; Xie S; Liu F; Iqbal K
Alzheimers Dement; 2016 Oct; 12(10):1066-1077. PubMed ID: 27133892
[TBL] [Abstract][Full Text] [Related]
35. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
[TBL] [Abstract][Full Text] [Related]
36. EFhd2 is a novel amyloid protein associated with pathological tau in Alzheimer's disease.
Ferrer-Acosta Y; Rodríguez-Cruz EN; Orange F; De Jesús-Cortés H; Madera B; Vaquer-Alicea J; Ballester J; Guinel MJ; Bloom GS; Vega IE
J Neurochem; 2013 Jun; 125(6):921-31. PubMed ID: 23331044
[TBL] [Abstract][Full Text] [Related]
37. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
[TBL] [Abstract][Full Text] [Related]
38. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.
Tran HT; LaFerla FM; Holtzman DM; Brody DL
J Neurosci; 2011 Jun; 31(26):9513-25. PubMed ID: 21715616
[TBL] [Abstract][Full Text] [Related]
39. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.
Rissman RA; Poon WW; Blurton-Jones M; Oddo S; Torp R; Vitek MP; LaFerla FM; Rohn TT; Cotman CW
J Clin Invest; 2004 Jul; 114(1):121-30. PubMed ID: 15232619
[TBL] [Abstract][Full Text] [Related]
40. Role of PrP(C) Expression in Tau Protein Levels and Phosphorylation in Alzheimer's Disease Evolution.
Vergara C; Ordóñez-Gutiérrez L; Wandosell F; Ferrer I; del Río JA; Gavín R
Mol Neurobiol; 2015; 51(3):1206-20. PubMed ID: 24965601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
